6th Jan 2009 15:23
ReGen Therapeutics Plc
For immediate release
6 January 2009
ReGen Therapeutics Plc
Results of General Meeting
ReGen Therapeutics plc (the "Company") announces that, at the General Meeting of the Company held earlier today, Shareholders passed all the resolutions proposed and as detailed in the circular sent to Shareholders dated 12 December 2008.
In addition, the Chairman confirmed that the Company is continuing with its plan to accelerate its revenue generation from Colostrinin™ to provide stability for the business and that, based on current interest for Colostrinin™, he anticipates the Company reaching its objective of achieving profitability by the end of Q4 2009.
For further information:
Percy Lomax
ReGen Therapeutics plc
Tel No. 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish
Tel No. 020 7628 3396
David Scott/Nick Bealer
Alexander David
Tel No. 020 7448 9820
Related Shares:
TILS.L